Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Marshall Edwards shares crash on PhIII cancer failure
Fierce Biotech
Wednesday, June 2, 2010 - 9:29am
tags:
Marshall Edwards, ovarian cancer, phenoxodiol, Novogen
Large pharma to boost CMOs’ biologics business; report
Outsourcing Pharma
Wednesday, June 2, 2010 - 9:03am
tags:
contract drug manufacturing, biologics
GSK settles first Avandia case in USA
Pharma Times, UK
Wednesday, June 2, 2010 - 8:36am
tags:
GSK, Avandia, diabetes, settlements
Risk of Miscarriage Linked to Antidepressants
Bloomberg Businessweek
Wednesday, June 2, 2010 - 8:35am
tags:
antidepressants, miscarriage, Paxil, Effexor, SSRIs
Rising Dollar Adds Pressure For US Drug, Device Makers
NASDAQ.com
Wednesday, June 2, 2010 - 8:31am
tags:
Europe, exports
Healthcare Market Perceptions create Expectations for Pharmaceutical Companies
Pharmareform
Wednesday, June 2, 2010 - 8:30am
tags:
healthcare reform
Shire's 'unflappable' CEO a foe of inertia
Fierce Pharma
Wednesday, June 2, 2010 - 8:29am
tags:
Shire, Pharma CEOs, Angus Russell
Safety Concerns Unlikely to Delay FDA Approval of Novartis' MS Drug Gilenia
BNET Pharma
Wednesday, June 2, 2010 - 8:25am
tags:
Novartis, MS, multiple sclerosis, Gilenia
Eisai’s Breast Cancer Drug Gets Priority Review
Bloomberg
Wednesday, June 2, 2010 - 8:24am
tags:
Eisai, FDA, breast cancer, Eribulin
Alexion Accelerates Plans to Launch Soliris® (Eculizumab) in Japan
Yahoo
Wednesday, June 2, 2010 - 8:23am
tags:
Alexion, Japan, Soliris, PNH
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Seeking Alpha
Wednesday, June 2, 2010 - 8:22am
tags:
Amgen, Prolia, osteoporosis, FDA
FDA clears Amgen's bone-strengthening drug, Prolia
Yahoo/AP
Wednesday, June 2, 2010 - 8:21am
tags:
FDA, Prolia, Amgen, GSK, Merck, Zemeta, Fosamax, osteoporosis
Teva Pharmaceutical launches generic Yaz
Yahoo/AP
Tuesday, June 1, 2010 - 6:02pm
tags:
Teva Pharmaceuticals, generics, Yaz, birth control pill, Bayer
Dr. Reddy's Laboratories Continues to Impress
Seeking Alpha
Tuesday, June 1, 2010 - 6:01pm
tags:
Dr Reddy's
Save Your Money, Dendreon
Motley Fool
Tuesday, June 1, 2010 - 6:00pm
tags:
Dendreon, prostate cancer, Provenge
Patent Ownership And Federally Funded Research
Pharmalot
Tuesday, June 1, 2010 - 1:02pm
tags:
patents, R&D
Pfizer, China, A Vaccine And Intellectual Property
Pharmalot
Tuesday, June 1, 2010 - 9:22am
tags:
vaccines, intellectual property, Pfizer, China
Financial climate better for potential delivery unit sale, says Elan
In-Pharma Technologist
Tuesday, June 1, 2010 - 9:19am
tags:
M&A, Elan, drug delivery
Researcher: New vaccine "could eliminate breast cancer"
Fierce Biotech Research
Tuesday, June 1, 2010 - 9:18am
tags:
vaccines, breast cancer
CSL Recalls Flu Shot as Side Effects Rise Nine-Fold
Bloomberg
Tuesday, June 1, 2010 - 9:07am
tags:
Flu, vaccines, CSL, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.